Combination Chemotherapy for Metastatic Breast Cancer

Phase II Study of Gemcitabine Plus Cisplatin as First-line Treatment of Metastatic Breast Cancer

The purpose of this study is to determine the objective tumor response of the first-line therapy combination of gemcitabine and cisplatin in patients with metastatic breast cancer

Inclusion Criteria:

• You are female in the age of 18 to 75 years old.
• You have been diagnosed with the metastatic breast cancer.
• You have desire and an opportunity to visit your doctor in medical site, both during realization of the active treatment program, and within 24 months of medical follow up.
• You must sign this informed consent form

Exclusion Criteria:

• You are pregnant or breastfeeding.
• Your laboratory parameters fall outside the limits, admitted by requirements of the present clinical study.
• You have been diagnosed with serious concomitant or acute infectious disease.
• You have used experimental medications within the last month.